Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
KDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
APIs
Reply
31 Jul 2024
Reply
07 Feb 2024
Reply
17 Jan 2023
Reply
21 Feb 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A Evogliptin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Evogliptin, including repackagers and relabelers. The FDA regulates Evogliptin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Evogliptin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Evogliptin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Evogliptin supplier is an individual or a company that provides Evogliptin active pharmaceutical ingredient (API) or Evogliptin finished formulations upon request. The Evogliptin suppliers may include Evogliptin API manufacturers, exporters, distributors and traders.
click here to find a list of Evogliptin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Evogliptin Drug Master File in Korea (Evogliptin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Evogliptin. The MFDS reviews the Evogliptin KDMF as part of the drug registration process and uses the information provided in the Evogliptin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Evogliptin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Evogliptin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Evogliptin suppliers with KDMF on PharmaCompass.
Evogliptin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Evogliptin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Evogliptin GMP manufacturer or Evogliptin GMP API supplier for your needs.
A Evogliptin CoA (Certificate of Analysis) is a formal document that attests to Evogliptin's compliance with Evogliptin specifications and serves as a tool for batch-level quality control.
Evogliptin CoA mostly includes findings from lab analyses of a specific batch. For each Evogliptin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Evogliptin may be tested according to a variety of international standards, such as European Pharmacopoeia (Evogliptin EP), Evogliptin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Evogliptin USP).
LOOKING FOR A SUPPLIER?
Comment (3)
